西罗莫司-话题@MedSci

#西罗莫司#

37篇内容 | 2206人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1340039, encodeId=057513400394d, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=结节性硬化症突破性疗法：西罗莫司凝胶, objectType=article, longId=136294, objectId=ec0f13629473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec0f13629473, replyNumber=0, likeNumber=89, createdTime=2018-04-25, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec0f13629473, moduleTitle=结节性硬化症突破性疗法：西罗莫司凝胶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec0f13629473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340038, encodeId=b66e134003839, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=罕见病DIPNECH综合征的治疗：口服西罗莫司, objectType=article, longId=136293, objectId=1cb013629357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cb013629357, replyNumber=0, likeNumber=62, createdTime=2018-04-25, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cb013629357, moduleTitle=罕见病DIPNECH综合征的治疗：口服西罗莫司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cb013629357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340037, encodeId=b25d134003ef6, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂, objectType=article, longId=134609, objectId=58c1134609a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c1134609a6, replyNumber=0, likeNumber=55, createdTime=2018-04-10, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c1134609a6, moduleTitle=JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c1134609a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340036, encodeId=41221340036e5, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=JACC：西罗莫司缓解心脏移植后免疫反应更佳, objectType=article, longId=129447, objectId=9c0612944e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c0612944e71, replyNumber=0, likeNumber=78, createdTime=2018-02-11, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c0612944e71, moduleTitle=JACC：西罗莫司缓解心脏移植后免疫反应更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c0612944e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340035, encodeId=5a1813400357e, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=ANN Oncol：吉西他滨联合西罗莫司治疗复发性骨肉瘤, objectType=article, longId=124838, objectId=9f9912483844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9912483844, replyNumber=0, likeNumber=79, createdTime=2017-12-29, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9912483844, moduleTitle=ANN Oncol：吉西他滨联合西罗莫司治疗复发性骨肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9912483844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340034, encodeId=53741340034a8, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=RAY研究（MCL 3001）：伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究, objectType=article, longId=116559, objectId=340511655922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=340511655922, replyNumber=0, likeNumber=77, createdTime=2017-10-19, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=340511655922, moduleTitle=RAY研究（MCL 3001）：伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=340511655922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340033, encodeId=ee1413400332a, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究(RAY研究, MCL 3001), objectType=article, longId=113568, objectId=9b57113568f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b57113568f5, replyNumber=0, likeNumber=74, createdTime=2017-09-23, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b57113568f5, moduleTitle=伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究(RAY研究, MCL 3001), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b57113568f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340032, encodeId=bf561340032ae, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Chest:西罗莫司治疗肺淋巴管平滑肌瘤病是否安全有效？, objectType=article, longId=106694, objectId=49af10669400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49af10669400, replyNumber=0, likeNumber=80, createdTime=2017-07-27, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49af10669400, moduleTitle=Chest:西罗莫司治疗肺淋巴管平滑肌瘤病是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49af10669400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340031, encodeId=ca8e13400312e, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Chest：西罗莫司和淋巴管肌瘤病中的自噬抑制：I期临床试验结果, objectType=article, longId=101487, objectId=0ee810148e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ee810148e65, replyNumber=0, likeNumber=90, createdTime=2017-06-12, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ee810148e65, moduleTitle=Chest：西罗莫司和淋巴管肌瘤病中的自噬抑制：I期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ee810148e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340030, encodeId=7fcf1340030d2, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Chest：西罗莫司对淋巴管平滑肌瘤病患者血清VEGF-D水平的长期影响, objectType=article, longId=99743, objectId=eaf499e43fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaf499e43fa, replyNumber=0, likeNumber=68, createdTime=2017-05-28, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaf499e43fa, moduleTitle=Chest：西罗莫司对淋巴管平滑肌瘤病患者血清VEGF-D水平的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaf499e43fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340029, encodeId=4577134002993, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=CHEST：西罗莫司和自噬抑制对LAM治疗效果的I期临床试验, objectType=article, longId=89044, objectId=75b08904459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b08904459, replyNumber=0, likeNumber=0, createdTime=2017-02-17, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b08904459, moduleTitle=CHEST：西罗莫司和自噬抑制对LAM治疗效果的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b08904459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340028, encodeId=296e134002865, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Lancet：可生物降解的支架效果如何？三种药物洗脱支架比较：依维莫司、西罗莫司、佐他莫司, objectType=article, longId=81638, objectId=7d0e8163896, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0e8163896, replyNumber=0, likeNumber=80, createdTime=2016-11-03, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0e8163896, moduleTitle=Lancet：可生物降解的支架效果如何？三种药物洗脱支架比较：依维莫司、西罗莫司、佐他莫司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0e8163896)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340027, encodeId=f405134002ead, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架, objectType=article, longId=63339, objectId=8a316333963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a316333963, replyNumber=0, likeNumber=59, createdTime=2016-02-18, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a316333963, moduleTitle=JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a316333963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340026, encodeId=f20d134002659, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Lancet：依鲁替尼 vs 替西罗莫司治疗套细胞淋巴瘤, objectType=article, longId=60386, objectId=b9d8603867a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9d8603867a, replyNumber=0, likeNumber=70, createdTime=2015-12-09, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9d8603867a, moduleTitle=Lancet：依鲁替尼 vs 替西罗莫司治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9d8603867a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340025, encodeId=8da013400258b, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=Lancet：佐他莫司与西罗莫司洗脱支架血栓风险均低, objectType=article, longId=9424, objectId=9891942455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9891942455, replyNumber=0, likeNumber=89, createdTime=2012-09-01, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9891942455, moduleTitle=Lancet：佐他莫司与西罗莫司洗脱支架血栓风险均低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9891942455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340024, encodeId=368f1340024e0, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=NEJM：从钙调神经磷酸酶抑制剂换为西罗莫司降低肾移植病人患新皮肤癌, objectType=article, longId=8403, objectId=dd72840368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd72840368, replyNumber=0, likeNumber=103, createdTime=2012-08-02, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd72840368, moduleTitle=NEJM：从钙调神经磷酸酶抑制剂换为西罗莫司降低肾移植病人患新皮肤癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd72840368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340023, encodeId=ea62134002383, content=<a href='/topic/show?id=8c519053e85' target=_blank style='color:#2F92EE;'>#西罗莫司#</a>, objectTitle=西罗莫司联合环磷酰胺治疗晚期肉瘤耐受良好, objectType=article, longId=2773, objectId=df442e7348, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df442e7348, replyNumber=0, likeNumber=75, createdTime=2011-07-02, rootId=0, userName=ms3415360956839622, userId=c7de2500155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df442e7348, moduleTitle=西罗莫司联合环磷酰胺治疗晚期肉瘤耐受良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df442e7348)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

西罗莫司

2020-05-29

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

结节性硬化症突破性疗法：西罗莫司凝胶

2018-04-25

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

罕见病DIPNECH综合征的治疗：口服西罗莫司

2018-04-25

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

JACC:心脏移植后初始免疫抑制治疗：西罗莫司vs钙调神经磷酸酶抑制剂

2018-04-10

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

JACC：西罗莫司缓解心脏移植后免疫反应更佳

2018-02-11

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

ANN Oncol：吉西他滨联合西罗莫司治疗复发性骨肉瘤

2017-12-29

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

RAY研究（MCL 3001）：伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究

2017-10-19

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

伊布替尼VS西罗莫司在RR MCL患者中疗效：一项随机对照开放性多中心Ⅲ期研究(RAY研究, MCL 3001)

2017-09-23

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Chest:西罗莫司治疗肺淋巴管平滑肌瘤病是否安全有效？

2017-07-27

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Chest：西罗莫司和淋巴管肌瘤病中的自噬抑制：I期临床试验结果

2017-06-12

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Chest：西罗莫司对淋巴管平滑肌瘤病患者血清VEGF-D水平的长期影响

2017-05-28

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

CHEST：西罗莫司和自噬抑制对LAM治疗效果的I期临床试验

2017-02-17

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Lancet：可生物降解的支架效果如何？三种药物洗脱支架比较：依维莫司、西罗莫司、佐他莫司

2016-11-03

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

JACC：依维莫司洗脱支架的长期安全性优于西罗莫司洗脱支架

2016-02-18

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Lancet：依鲁替尼 vs 替西罗莫司治疗套细胞淋巴瘤

2015-12-09

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

Lancet：佐他莫司与西罗莫司洗脱支架血栓风险均低

2012-09-01

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

NEJM：从钙调神经磷酸酶抑制剂换为西罗莫司降低肾移植病人患新皮肤癌

2012-08-02

ms3415360956839622 (审核中...)

前往app查看评论内容

#西罗莫司#

西罗莫司联合环磷酰胺治疗晚期肉瘤耐受良好

2011-07-02

科室
- - 订阅+
  - 更多科室
工具
服务